2-(((1S,9S)-9-Ethyl-5-fluoro-9-hydroxy-4-methyl-10,13-dioxo-2,3,9,10,13,15-hexahydro-1H,12H-benzo[de]pyrano[3',4':6,7]indolizino[1,2-b]quinolin-1-yl)amino)-2-oxoethyl ((S)-8-benzyl-21-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-4,7,10,13,16-pentaoxo-3,6,9,12,15-pentaazahenicosyl)(methyl)carbamate

In House Impurity

Stock Status : <%stockStatus%>

<%deliveryStatus%>

Catalogue number:	PA 05 1991032
Chemical name:	2-(((1S,9S)-9-Ethyl-5-fluoro-9-hydroxy-4-methyl-10,13-dioxo-2,3,9,10,13,15-hexahydro-1H,12H-benzo[de]pyrano[3',4':6,7]indolizino[1,2-b]quinolin-1-yl)amino)-2-oxoethyl ((S)-8-benzyl-21-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-4,7,10,13,16-pentaoxo-3,6,9,12,15-pentaazahenicosyl)(methyl)carbamate
CAS Number:	2718125-83-6
Category:	Fine Chemicals,pharmaceutical standards,metabolites,impurities,intermediates,Antibody Drug Conjugate
Synonyms:	NA
Molecular form:	C₅₅H₆₁FN₁₀O₁₄
Appearance:	NA
Mol. Weight:	1105.15
Storage:	2-8°C Refrigerator
Shipping Conditions:	Ambient
Applications:	LE01 is a drug-linker conjugate for ADC. LE01 contains a ADC linker and a DNA topoisomerase I inhibitor DXd (HY-13631D). LE01 can be used to synthesize HER2-targeting ADC (HER2-LE01)